anmelden
Stoxx Europe 50
5.111,86
PKT
+29,54
PKT
+0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 03.02.22 | Novartis Neutral | Credit Suisse Group | |
| 03.02.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 03.02.22 | BBVA Buy | Jefferies & Company Inc. | |
| 03.02.22 | Roche Buy | Jefferies & Company Inc. | |
| 03.02.22 | ING Group Neutral | Goldman Sachs Group Inc. | |
| 03.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.02.22 | Deutsche Telekom Buy | Jefferies & Company Inc. | |
| 03.02.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 02.02.22 | Novo Nordisk Outperform | Bernstein Research | |
| 02.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.22 | Rio Tinto Sell | UBS AG | |
| 02.02.22 | Novartis Market-Perform | Bernstein Research | |
| 02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.02.22 | LVMH Moet Hennessy Louis Vuitton Overweight | Barclays Capital | |
| 02.02.22 | Santander Sector Perform | RBC Capital Markets | |
| 02.02.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Novartis Underweight | Barclays Capital | |
| 02.02.22 | Zurich Insurance Overweight | Barclays Capital | |
| 02.02.22 | AXA Overweight | Barclays Capital | |
| 02.02.22 | Allianz Equal Weight | Barclays Capital | |
| 02.02.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | UBS Equal Weight | Barclays Capital | |
| 02.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | Santander Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | Santander Hold | Jefferies & Company Inc. | |
| 02.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 02.02.22 | Novartis Buy | Jefferies & Company Inc. | |
| 02.02.22 | UBS Outperform | Credit Suisse Group | |
| 02.02.22 | UBS Outperform | RBC Capital Markets | |
| 02.02.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.02.22 | EssilorLuxottica Hold | Jefferies & Company Inc. | |
| 01.02.22 | Intesa Sanpaolo Hold | Jefferies & Company Inc. | |
| 01.02.22 | Münchener Rückversicherungs-Gesellschaft Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.22 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.22 | UBS Outperform | RBC Capital Markets | |
| 01.02.22 | SAP Buy | Warburg Research |